Jane Street Group, LLC Biora Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $8,237 - $762,329	-63,369 Reduced 85.53%	10,724 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $13.3 $16,982 - $426,171	32,043 Added 76.2%	74,093 $36,000
Q2 2022 Aug 16, 2022	SELL	$0.56 - $1.22 $146,531 - $319,230	-261,664 Reduced 86.15%	42,050 $29,000
Q1 2022 May 17, 2022	BUY	$1.11 - $2.25 $53,645 - $108,740	48,329 Added 18.92%	303,714 $353,000
Q4 2021 Feb 15, 2022	BUY	$1.35 - $4.89 $260,626 - $944,048	193,057 Added 309.74%	255,385 $534,000
Q3 2021 Nov 16, 2021	BUY	$0.67 - $3.41 $41,759 - $212,538	62,328 New	62,328 $95,000
Q1 2021 May 18, 2021	SELL	$3.91 - $7.31 $39,827 - $74,459	-10,186 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$3.27 - $9.48 $33,308 - $96,563	10,186 New	10,186 $54,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.